Skip to content
235235235

Drawing based on the description in the official product monograph. No photo yet.

“40 mg tablets are light yellow, round-shaped, film-coated tablets debossed with the Astellas logo and '235' on the same side”

235 pill

Pill with imprint 235 is yellow, round and has been identified as Gilteritinib Fumarate 40 mg. It is used for acute myeloid leukemia. It is supplied by Astellas Pharma Canada Inc.

Sold in Canada

Gilteritinib Fumarate 40 mg

Brand
Xospata
Imprint
235
Strength
40 mg
Used for
Acute myeloid leukemia
Color
Yellow
Shape
Round
Form
Tablet
Manufacturer
Astellas Pharma Canada Inc
Sold in
Canada
DIN
02495058

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Gilteritinib pills and guides

What is Gilteritinib used for?

Gilteritinib is used for acute myeloid leukemia.

Official uses from the US prescribing label

Relapsed or Refractory Acute Myeloid Leukemia

XOSPATA is indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FMS-like tyrosine kinase 3 (FLT3) mutation as detected by an FDA-approved test.

From the FDA-approved label on DailyMed (published Sep 21, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows 235.
  • It is yellow, round.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as Xospata by Astellas Pharma Canada Inc.

In Canada: prescription only.

Ingredients

Active: Gilteritinib (Gilteritinib Fumarate)

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Gilteritinib pills